Answers are grounded in this paper and cite their sources.
This editorial summarizes recent advances in research and management of testicular cancer which were presented at the 6th Copenhagen Workshop on Carcinoma in situ Testis and Germ Cell Cancer, held in Denmark, 26–28 October 2006. The focus of the meeting was on environment–genetics interphase and developmental aspects in the pathogenesis of testis cancer and related disorders, embryonic stem cell-like features of testicular germ cell tumours, new data from gene expression profiling, lessons from studies in animal models as well as clinical issues concerning early diagnosis and preservation of fertility. The emerging candidate pathways likely to be involved in the pathogenesis of testicular cancer, and possible future directions indicated at the meeting are briefly discussed. Recent years have witnessed an explosive growth in the research on testicular cancer, largely owing to the following aspects: Growing interest in stem cell biology: the research community ‘discovered’ what pathologists have known for decades – that testicular germ cell tumours (TGCT) are pluripotent and are a good model for studies of mechanisms of pluripotency, free of ethical issues connected to human embryonic stem (ES) cells (Donovan & de Miguel, 2003; Solter, 2006). The so-called ‘testicular dysgenesis syndrome (TDS) effect’: this hypothesis linked testicular cancer with other congenital disorders of male reproduction (cryptorchidism, hypospadias and some forms of decreased spermatogenesis) in one syndrome which is a result of impaired fetal development of the testis, caused by a combination of genetic predisposition and deleterious environmental factors (Skakkebæk et al., 2001). The link between testicular cancer and other disorders attracted the attention of paediatricians, urologists, andrologists, pathologists, geneticists, and – importantly – epidemiologists, who launched new studies to find relevant risk factors in order to corroborate or disprove this hypothesis. Progress in high-throughput methods of molecular biology: micro-array studies of gene expression profiles and genomic aberrations provided a large amount of new data and new hypothetical pathways involved in the pathogenesis of TGCT. These and other issues were discussed at the 6th Copenhagen Workshop on Carcinoma in situ Testis and Germ Cell Cancer and most of the scientific presentations in the printed form are grouped in this special issue. Epidemiology of TGCT and TDS was the first topic discussed at the meeting. As an introduction Skakkebæk reiterated the TDS hypothesis with focus on testicular cancer and its remarkable association with other growing problems of the reproductive development in a given population (e.g. genital malformations and infertility), suggesting a likely influence of adverse environmental factors that specifically target prenatal gonadal development (Skakkebæk et al., 2007). McGlynn and Møller presented data from the US and UK, respectively, and confirmed that testicular cancer continues to rise in most populations but with remarkable ethnic differences, indicating the influence of genetic background (Jack et al., 2007; Shah et al., 2007). Relative roles of hereditary vs. environmental factors in the aetiology of different forms of TDS were critically discussed by Richiardi, who also suggested that there may be an important aetiological factor(s) operating around puberty, based on the higher incidence rates of TGCT in men with the history of late orchidopexy compared to those who were operated early (Richiardi et al., 2007). An alternative explanation of this finding is the induction of further invasive transformation of an existing transformed gonocyte or pre-carcinoma in situ (‘pre-CIS’) cell during ‘adaptation’ to the changed hormonal microenvironment in the testis at the time of puberty (Rajpert-De Meyts & Skakkebæk, 2000), as schematically depicted in Fig. 1. A hypothetical model of the origin and progression of testicular germ cell tumours (TGCT) which have been rising in many countries, and presumed to have of a strong environmental component. Only TGCTs that are derived from carcinoma in situ (CIS) cells and which are parts of the testis dysgenesis syndrome (TDS) are considered here (rare infantile germ cell tumours and spermatocytic seminoma are not included). The key events in the origin and progression of TGCT are schematically presented (modified from Rajpert-De Meyts, 2006). Newer candidate genes and pathways which were discussed at the 6th Workshop on CIS Testis and Germ Cell Cancer are added to the scheme. The importance of prenatal events was stressed by Main, who presented the emerging evidence for an exposure to endocrine disrupters (detected in breast milk) as a possible explanation for a striking difference in the incidence of cryptorchidism between Denmark and Finland (Damgaard et al., 2006). She also discussed the fascinating data demonstrating a difference in the testis volume and concentration of inhibin B between infant cohorts in the two countries, indicative of early subtle manifestation of adverse environmental factors in Denmark, although a genuine genetic difference cannot be excluded (Main et al., 2006). Further search for even more sensitive markers of exposure is one of the future directions in this area of research. The primary importance of the intrauterine exposures to environmental chemicals (e.g. pesticides) as opposed to the lack of effects of occupational exposure in the aetiology of TGCT was also stressed by Thonneau (Walschaerts et al., 2007). The ‘nature vs. nurture’ discussion was continued by Starr and Nathanson, who presented recent findings on polymorphisms in genes encoding oestrogen and androgen metabolizing enzymes. Starr has also presented a novel population-based, case–parent triad methodology for these kind of studies (Starr et al., 2005). She concluded that maternal genotypes, for example in genes involved in the steroid hormone metabolism pathways, might have a primary importance for the risk of testicular cancer in the son, although the uterine environment may be equally important. Future directions in this area will need to include detailed and well controlled investigations of maternal and male offspring genotypes with focus on genes involved in hormonal/paracrine regulation of testis function that may be targeted by known endocrine disrupters. An underlying genetic problem is considered of primary importance in familial TGCT. However, classical linkage studies performed in large pedigrees have been disappointing so far, and the only positive associations with the TGCT risk, such as partial deletions of the azoospermia factor region c (AZFc, so-called gr/gr deletions) were found by the candidate gene approach (reviewed in Rapley, 2007). Bilateral testicular cancer is also considered by many to have a stronger hereditary component than sporadic unilateral tumours. This question was addressed by Harland, who demonstrated preliminary results of a large questionnaire study that confirmed a greater risk of cancer in brothers of patients with bilateral disease. On the other hand, the prevalence of bilateral TGCT in families calculated by statistical genetics was much lower than the theoretical prediction based on estimates of penetrance (Harland et al., 2007). The consensus is growing that testicular cancer is a complex polygenic disease and a different gene may be involved in each family. Identification of these genes is difficult because of low penetrance of the genotype, recessive mode of inheritance and environmental influences. A good direction to go might be focusing on ethnic differences and populations with the same ethnicity but with variable incidence rates. While there is a general consensus concerning the importance of environmental factors in the pathogenesis of TDS and testicular neoplasia, the knowledge of the mechanistic pathways remains very limited. Developmental delay undoubtedly plays the key role (Fig. 1) but the relative involvement of germ cells vs. somatic cells has been discussed. The mechanistic pathways are very difficult to study in man, especially if one has to investigate early gonad development. Here the lessons from animal models may be very helpful. Some of the effects observed in rodents after exposure to selected endocrine disrupters, primarily those with anti-androgenic activity, may be of particular relevance to human pathology. Sharpe reviewed the consequences of a prenatal exposure to phthalates in rats which strikingly resembled human TDS, with a focal disruption of tissue architecture in the testis, decreased numbers of Sertoli cells, formation of large aggregates or intratubular entrapment of Leydig cells, and signs of delayed differentiation and proliferation of germ cells with a frequent appearance of multinucleated gonocytes but no malignant transformation (Ferrara et al., 2006). We only begin to understand the mechanisms involved in the observed changes. In addition to the androgen signalling there is a large number of candidate pathways to explore, including pathways regulating the transforming growth factor β superfamily (e.g. activins) as discussed at the meeting by Loveland (Loveland et al., 2007). A novel idea of how endocrine disrupters may work was presented by Skinner, who reviewed the unexpected effects on adult spermatogenesis in rats after transient exposure during sex determination to vinclozolin and methoxychlor. The transfer of the effect to the next generation was most likely caused by alterations in epigenetic programming of the germ line (Skinner, 2007). Although the rats did not develop tumours, these findings may have implications for human TGCTs, which are known for instability of their epigenetic profile, as discussed by Lothe and Okamoto (Okamoto & Kawakami, 2007). A main problem with small rodent models is that they do not develop TGCT that are equivalent of human seminomas, and no preinvasive CIS-like cells have been described. Seminoma-like TGCTs described in various species, including mice, dogs, fish (presented at the meeting by J.F. Amatruda) or even Drosophila (Hime et al., 2007) are usually a result of aberrant proliferation of mature germ cells in adult animals and are most likely equivalents of human spermatocytic seminoma, a rare TGCT found in relatively older men (Looijenga et al., 2007a). As presented at the meeting by Matin and Heaney, mice of the 129/Sv strain and its consomic variants develop teratomas, often congenital, which occur with a high frequency modulated by deletion or inactivation of different regions/genes/, e.g. Ay or dnd1 (Matin, 2007). However, this model may be very useful to study human teratomas that occur in infants (Oosterhuis et al., 2007). Despite the limitations of animal models, studies in mice and rats are indispensable to shed light on the various aspects of biology and primordial germ cells (PGC) as well as sexual differentiation and maturation of early gonads, as a better understanding of these mechanisms is absolutely necessary to elucidate the process of neoplastic transformation. Some of these aspects were discussed at the workshop but due to space limitations, I can only name the key pathways most relevant to the pathogenesis of human TGCT. Factors involved in the PGC survival during migration (e.g. Steel/c-kit system) were discussed by Wylie and his colleague (Runyan et al., 2006). These exciting findings are, of course, very important to understand how human PGC survive in the midline and form tumours in extragonadal locations (reviewed in Oosterhuis et al., 2007). The sex-dimorphic regulation of the mitosis–meiosis switch in fetal gonads was the main topic presented by Page (see Kimble & Page, 2007). This is of relevance to the human TGCT, where the problems with somatic regulation of sexual differentiation and mitotic arrest, possibly causing ensuing errors in genome replication, are suspected to be involved in the initiation of the neoplastic transformation. In support of this hypothesis, Bartkova presented data illustrating profound differences in the regulation of DNA repair and the cell cycle machinery in human gonocytes and TGCT in comparison with somatic cells or mature germ cells undergoing meiosis in the adult testis (Bartkova et al., 2007). Closely related aspects of the somatic-germ cell cross-talk in murine testes, including the regulation of expression of mitotic arrest and pluripotency genes, were discussed by A. Sinclair, while H. Schorle and D. Zarkower presented novel data on two very interesting factors, AP-2γ (Eckert et al., 2005) and Dmrt1 (Kim et al., 2007), respectively, which are currently investigated for their involvement in human testicular carcinogenesis. AP-2γ is probably involved in a regulation of KIT, the above-mentioned key regulator of germ cell survival. A detailed study of the regulation of KIT signalling in a mouse model exposed to imatinib, an inhibitor of KIT and PDGFR, was presented by Toppari (Nurmio et al., 2007). Another key event implicated in the neoplastic process in human germ cells is a block in gonocyte differentiation which most likely has something to do with the impairment of the regulation of embryonic pluripotency genes that are physiologically downregulated as gonocytes differentiate into infantile spermatogonia, as schematically depicted in Fig. 1 (reviewed in Rajpert-De Meyts, 2006). Therefore, the possible involvement of the pluripotency factors in malignant transformation of germ cells was one of the main topics of the meeting. The current state of knowledge on the specification of human germ cells from ES cells and the opposite phenomenon observed in culture, with a careful consideration to pertinent ethical issues was reviewed by H.D. Moore, while Harrison summarized intriguing observations in cultured human ES cells, which undergo non-random chromosomal changes strikingly similar to genomic aberrations reported in TGCTs, such as gains in chromosome 12p (Harrison et al., 2007). A high expression of pluripotency genes, some of them mapped to 12p in CIS and overt TGCTs, but not in differentiated teratomas, was reported in several gene expression profiling studies, which were discussed at the meeting by Almstrup, Lothe and Chaganti (Skotheim et al., 2005; Korkola et al., 2006; Almstrup et al., 2007). One of the unresolved issues is what determines the progression of CIS cells into either seminomas or non-seminomatous tumours (Fig. 1). The answer has not yet been found but we are getting closer, thanks to new array studies of genomic imbalances combined with gene expression profiles, which were presented at the meeting by Shipley, Lothe, Chaganti, and the Honecker’s group. The Chaganti Laboratory identified several molecular markers of histological components of non-seminomas, which may have a clinical prognostic value (Korkola et al., 2005). Shipley presented elegant studies of somatic mutations of the KIT and RAS pathways, which may open new therapeutic approaches (Goddard et al., 2007). There was some discrepancy concerning the frequency of activating somatic KIT mutations in bilateral TGCT between the studies in Sutton and Rotterdam but the tumour-promoting effect of this mutation is beyond doubt. Some of the UK studies were performed using a TGCT cell line TCam-2, which appears to be an excellent model of a classical seminoma (Goddard et al., 2007), in contrast to another presumably seminoma-derived line, JKT-1, which has completely different expression profile, does not express pluripotency markers and is most likely derived from adult germ cells, thus it should not be used as a model for classical seminoma (De Jong et al., 2007). A great value of the novel high-throughput tools, such as micro-arrays, was very clearly demonstrated at the meeting, and these tools have contributed a wealth of new data on gene expression profiles and genome of TGCT. Even rare tumours, such as spermatocytic seminoma, were analysed in detail, as presented by Looijenga who identified a restricted chromosome 9p amplification associated with upregulation of DMRT1, and proposed the origin of this tumour from primary spermatocytes (Looijenga et al., 2007a). Gene expression studies at the RNA level contributed to the discovery of a completely new way of regulation of gene function by small non-coding RNAs, so-called miRNAs (micro RNAs) that were not yet known at the time of the previous workshop. At this workshop Leffers and Looijenga discussed data supporting their involvement in the regulation of genes involved in germ cell maturation and division during normal development and in TGCTs (Looijenga et al., 2007a,b; Novotny et al., 2007). This area of research will undoubtedly expand in the very near future and the identification of gene targets for miRNAs will surely contribute to the better understanding of the mechanisms of neoplastic transformation of germ cells. The workshop was primarily focused on basic research aspects of TGCT, but clinical aspects were also discussed. An association of TDS and germ cell neoplasia with male infertility was discussed by Tanrikut and Jørgensen (Olesen et al., 2007). Better definition of indications for contralateral biopsy was presented in studies by Kemper and Kliesch from Münster. Recent advances in the methods of diagnosis of CIS/incipient tumour were discussed by Hoei-Hansen, who reviewed the value of ultrasound examination and presented a detailed evaluation of an immunocytological assay for stem cell markers (AP-2γ or OCT-3/4) for the detection of neoplastic cells in semen samples (Hoei-Hansen et al., 2007). The value of OCT-3/4 for this purpose was also assessed in a preliminary manner in a poster by van Casteren and colleagues. The test is very promising but its low sensitivity requires substantial improvement, before the assay can be applied for screening in routine laboratories. Okamoto suggested XIST as a possible marker for disseminated seminoma (Okamoto & Kawakami, 2007). Horwich presented an update on the management of patients and risk factors associated with metastasis or resistance to therapy. Andersson reviewed the value of serum inhibin B for monitoring of the recovery of spermatogenesis after chemotherapy. The protocols for pre-treatment sperm banking in adult patients and fertility issues in cancer survivors were reviewed by Schmidt (Schmidt et al., 2007). The issue of preserving future fertility in young boys treated for cancer was taken on by Jahnukainen, who presented preliminary results of experimental studies aiming to develop methods of prepubertal germ cell cryo-preservation. In conclusion, the research on different aspects of pathogenesis and management of testicular cancer has been markedly expanded in recent years, and this meeting has been a reflection of recent progress. A great deal has been accomplished but many gaps of knowledge remain. Importantly, we have only a vague idea as to what causes TGCT. Lifestyle and environment undoubtedly are of primary importance, as shown by epidemiological trends. But we have not yet found the culprit that caused the dramatic increase in this cancer almost worldwide. Genetic predisposition also plays a role in the pathogenesis of testicular cancer, as clearly indicated by factors such as ethnic differences, but the underlying background is complex and most likely polygenic. The association of TGCT with congenital reproductive disorders, and phenotypic features of the precursor cell (CIS) strongly suggest that neoplastic transformation is initiated early in life, thus testicular cancer that is preceded by CIS may be considered a developmental disease. Finally, the unique biological features of TGCT, many of which were discussed at this meeting, for example pluripotency and phenotypic plasticity, unusual DNA repair regulation and epigenetic features, make this cancer a fascinating area of research which will hopefully attract interest from a growing number of researchers and support organizations.
No takes yet. Share an insight, caveat, or question.
Ewa Rajpert‐De Meyts (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: